| 0 |
VASCULAR ANASTOMOTIC HAEMORRHAGE |
24 |
0.8000 |
| 1 |
PSEUDOANEURYSM INFECTION |
41 |
0.7736 |
| 2 |
CYTOMEGALOVIRUS SYNDROME |
84 |
0.5091 |
| 3 |
IMMUNE RECOVERY UVEITIS |
27 |
0.4655 |
| 4 |
ENCEPHALITIS CYTOMEGALOVIRUS |
203 |
0.4635 |
| 5 |
CYTOMEGALOVIRUS NEPHRITIS |
22 |
0.4151 |
| 6 |
CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION |
102 |
0.3423 |
| 7 |
SMOOTH MUSCLE CELL NEOPLASM |
136 |
0.3254 |
| 8 |
PERICARDITIS FUNGAL |
20 |
0.3030 |
| 9 |
VENA CAVA INJURY |
25 |
0.2717 |
| 10 |
PERINEAL CYST |
19 |
0.2603 |
| 11 |
PYELONEPHRITIS FUNGAL |
19 |
0.2568 |
| 12 |
RETINITIS VIRAL |
30 |
0.2479 |
| 13 |
HUMAN EHRLICHIOSIS |
50 |
0.2392 |
| 14 |
CHORIOMENINGITIS LYMPHOCYTIC |
16 |
0.2319 |
| 15 |
CYTOMEGALOVIRUS OESOPHAGITIS |
85 |
0.2310 |
| 16 |
CYTOMEGALOVIRUS DUODENITIS |
16 |
0.2286 |
| 17 |
CYTOMEGALOVIRUS VIRAEMIA |
924 |
0.2075 |
| 18 |
CYTOMEGALOVIRUS GASTROENTERITIS |
44 |
0.2037 |
| 19 |
CYTOMEGALOVIRUS ENTERITIS |
71 |
0.1994 |
| 20 |
VASCULAR PSEUDOANEURYSM RUPTURED |
46 |
0.1983 |
| 21 |
DELAYED GRAFT FUNCTION |
134 |
0.1885 |
| 22 |
CYTOMEGALOVIRUS GASTRITIS |
47 |
0.1858 |
| 23 |
DISSEMINATED CYTOMEGALOVIRAL INFECTION |
39 |
0.1806 |
| 24 |
CEREBRAL NOCARDIOSIS |
41 |
0.1760 |
| 25 |
CYTOMEGALOVIRUS CHORIORETINITIS |
322 |
0.1650 |
| 26 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
676 |
0.1529 |
| 27 |
CYTOMEGALOVIRUS COLITIS |
345 |
0.1499 |
| 28 |
CUTANEOUS MUCORMYCOSIS |
27 |
0.1467 |
| 29 |
CUTANEOUS NOCARDIOSIS |
19 |
0.1462 |
| 30 |
NEW ONSET DIABETES AFTER TRANSPLANTATION |
25 |
0.1445 |
| 31 |
INTRACRANIAL INFECTION |
18 |
0.1440 |
| 32 |
RENAL CYST HAEMORRHAGE |
32 |
0.1416 |
| 33 |
RETROPERITONEAL ABSCESS |
17 |
0.1405 |
| 34 |
NEUTROPHIL PELGER-HUET ANOMALY PRESENT |
26 |
0.1390 |
| 35 |
CYTOMEGALOVIRUS INFECTION |
2219 |
0.1334 |
| 36 |
CYTOMEGALOVIRUS HEPATITIS |
47 |
0.1328 |
| 37 |
PNEUMONIA CYTOMEGALOVIRAL |
253 |
0.1301 |
| 38 |
DEAFNESS CONGENITAL |
26 |
0.1294 |
| 39 |
POLYOMAVIRUS VIRAEMIA |
133 |
0.1252 |
| 40 |
EPSTEIN-BARR VIRAEMIA |
138 |
0.1244 |
| 41 |
CONGENITAL CYTOMEGALOVIRUS INFECTION |
21 |
0.1235 |
| 42 |
DRUG RESISTANCE MUTATION |
21 |
0.1180 |
| 43 |
TRICHOPHYTOSIS |
25 |
0.1179 |
| 44 |
PARVOVIRUS B19 INFECTION |
105 |
0.1173 |
| 45 |
RENAL GRAFT INFECTION |
27 |
0.1164 |
| 46 |
ADENOVIRAL HEPATITIS |
27 |
0.1149 |
| 47 |
GASTROINTESTINAL MUCORMYCOSIS |
19 |
0.1138 |
| 48 |
SCEDOSPORIUM INFECTION |
79 |
0.1119 |
| 49 |
PERINEPHRIC COLLECTION |
16 |
0.1119 |
| 50 |
ACANTHAMOEBA INFECTION |
21 |
0.1117 |
| 51 |
LUNG TRANSPLANT REJECTION |
72 |
0.1091 |
| 52 |
BK VIRUS INFECTION |
362 |
0.1072 |
| 53 |
TERATOGENICITY |
32 |
0.1060 |
| 54 |
PULMONARY NOCARDIOSIS |
86 |
0.1044 |
| 55 |
VIRAL HAEMORRHAGIC CYSTITIS |
74 |
0.1039 |
| 56 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
234 |
0.0998 |
| 57 |
HUMAN HERPESVIRUS 8 INFECTION |
59 |
0.0969 |
| 58 |
CYTOMEGALOVIRUS TEST POSITIVE |
171 |
0.0959 |
| 59 |
UREAPLASMA INFECTION |
39 |
0.0956 |
| 60 |
CYTOMEGALOVIRUS ENTEROCOLITIS |
72 |
0.0935 |
| 61 |
TRANSPLANT DYSFUNCTION |
166 |
0.0929 |
| 62 |
CYTOMEGALOVIRUS ANTIGEN POSITIVE |
17 |
0.0929 |
| 63 |
DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION |
20 |
0.0905 |
| 64 |
PANCREAS TRANSPLANT REJECTION |
18 |
0.0896 |
| 65 |
TOXOPLASMOSIS |
96 |
0.0889 |
| 66 |
GRAFT LOSS |
63 |
0.0869 |
| 67 |
NECROTISING RETINITIS |
54 |
0.0844 |
| 68 |
ABDOMINAL WALL HAEMORRHAGE |
22 |
0.0843 |
| 69 |
TRANSPLANT REJECTION |
660 |
0.0823 |
| 70 |
COMPLICATIONS OF TRANSPLANTED LUNG |
25 |
0.0814 |
| 71 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
409 |
0.0803 |
| 72 |
RENAL TRANSPLANT FAILURE |
78 |
0.0789 |
| 73 |
DERMATOPHYTOSIS |
22 |
0.0775 |
| 74 |
MONKEYPOX |
21 |
0.0761 |
| 75 |
INFECTION REACTIVATION |
87 |
0.0760 |
| 76 |
VASCULAR COMPRESSION |
24 |
0.0759 |
| 77 |
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM |
23 |
0.0759 |
| 78 |
PULMONARY MUCORMYCOSIS |
40 |
0.0758 |
| 79 |
ENTEROCOLITIS VIRAL |
23 |
0.0757 |
| 80 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
169 |
0.0744 |
| 81 |
PARVOVIRUS INFECTION |
30 |
0.0743 |
| 82 |
MALACOPLAKIA |
34 |
0.0742 |
| 83 |
HUMAN HERPESVIRUS 6 ENCEPHALITIS |
21 |
0.0739 |
| 84 |
LYMPHOCELE |
48 |
0.0723 |
| 85 |
EYE INFECTION FUNGAL |
27 |
0.0698 |
| 86 |
MUCORMYCOSIS |
181 |
0.0696 |
| 87 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
91 |
0.0691 |
| 88 |
CENTRAL NERVOUS SYSTEM FUNGAL INFECTION |
16 |
0.0690 |
| 89 |
NOCARDIOSIS |
176 |
0.0688 |
| 90 |
EPSTEIN-BARR VIRUS INFECTION |
429 |
0.0686 |
| 91 |
DISSEMINATED ASPERGILLOSIS |
32 |
0.0678 |
| 92 |
KIDNEY TRANSPLANT REJECTION |
307 |
0.0639 |
| 93 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
86 |
0.0609 |
| 94 |
DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION |
22 |
0.0606 |
| 95 |
EYE INFECTION TOXOPLASMAL |
24 |
0.0605 |
| 96 |
HUMAN POLYOMAVIRUS INFECTION |
32 |
0.0603 |
| 97 |
CYSTITIS HAEMORRHAGIC |
242 |
0.0600 |
| 98 |
DISSEMINATED MUCORMYCOSIS |
23 |
0.0584 |
| 99 |
PENILE ULCERATION |
19 |
0.0581 |
| 100 |
OESOPHAGEAL ATRESIA |
36 |
0.0576 |
| 101 |
IDIOPATHIC PNEUMONIA SYNDROME |
17 |
0.0570 |
| 102 |
CITROBACTER INFECTION |
24 |
0.0559 |
| 103 |
STRONGYLOIDIASIS |
90 |
0.0557 |
| 104 |
GLOMERULOSCLEROSIS |
35 |
0.0554 |
| 105 |
CYSTITIS VIRAL |
21 |
0.0548 |
| 106 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
181 |
0.0547 |
| 107 |
FUNGAL ENDOCARDITIS |
16 |
0.0532 |
| 108 |
ENTEROCOCCAL INFECTION |
257 |
0.0531 |
| 109 |
INFECTION IN AN IMMUNOCOMPROMISED HOST |
38 |
0.0529 |
| 110 |
ADENOVIRUS INFECTION |
151 |
0.0520 |
| 111 |
BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED |
15 |
0.0517 |
| 112 |
GRAFT VERSUS HOST DISEASE IN SKIN |
114 |
0.0517 |
| 113 |
FUSARIUM INFECTION |
36 |
0.0514 |
| 114 |
CEREBRAL TOXOPLASMOSIS |
48 |
0.0514 |
| 115 |
MICROSPORIDIA INFECTION |
18 |
0.0513 |
| 116 |
PATHOGEN RESISTANCE |
450 |
0.0493 |
| 117 |
CEREBRAL ASPERGILLOSIS |
30 |
0.0488 |
| 118 |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS |
77 |
0.0480 |
| 119 |
ASPERGILLUS INFECTION |
312 |
0.0475 |
| 120 |
PROTEUS INFECTION |
34 |
0.0474 |
| 121 |
BLASTOMYCOSIS |
23 |
0.0473 |
| 122 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
83 |
0.0469 |
| 123 |
RENAL ARTERY STENOSIS |
64 |
0.0464 |
| 124 |
PNEUMOCYSTIS JIROVECII INFECTION |
55 |
0.0460 |
| 125 |
KLEBSIELLA INFECTION |
231 |
0.0456 |
| 126 |
VIRAEMIA |
63 |
0.0455 |
| 127 |
ACINETOBACTER INFECTION |
49 |
0.0447 |
| 128 |
TRICHODYSPLASIA SPINULOSA |
17 |
0.0446 |
| 129 |
COMPLICATIONS OF TRANSPLANTED LIVER |
16 |
0.0444 |
| 130 |
TRANSPLANT FAILURE |
108 |
0.0440 |
| 131 |
TRANSPLANTATION COMPLICATION |
18 |
0.0429 |
| 132 |
STENOTROPHOMONAS INFECTION |
58 |
0.0427 |
| 133 |
HUMAN HERPESVIRUS 6 INFECTION REACTIVATION |
15 |
0.0427 |
| 134 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
91 |
0.0427 |
| 135 |
INFECTIVE ANEURYSM |
21 |
0.0424 |
| 136 |
CRYPTOCOCCOSIS |
69 |
0.0423 |
| 137 |
HERPES SIMPLEX REACTIVATION |
16 |
0.0420 |
| 138 |
CORONA VIRUS INFECTION |
18 |
0.0419 |
| 139 |
ENTEROVIRUS INFECTION |
36 |
0.0417 |
| 140 |
FUNGAL SEPSIS |
34 |
0.0409 |
| 141 |
GRAFT VERSUS HOST DISEASE |
292 |
0.0406 |
| 142 |
PERICARDITIS CONSTRICTIVE |
17 |
0.0403 |
| 143 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
110 |
0.0398 |
| 144 |
CHRONIC ALLOGRAFT NEPHROPATHY |
31 |
0.0396 |
| 145 |
BRAIN ABSCESS |
100 |
0.0395 |
| 146 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
28 |
0.0389 |
| 147 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
287 |
0.0382 |
| 148 |
JC VIRUS INFECTION |
61 |
0.0381 |
| 149 |
ACUTE GRAFT VERSUS HOST DISEASE |
173 |
0.0378 |
| 150 |
GRAFT VERSUS HOST DISEASE IN LUNG |
18 |
0.0377 |
| 151 |
RENAL TUBULAR ATROPHY |
32 |
0.0363 |
| 152 |
DRUG RESISTANCE |
927 |
0.0361 |
| 153 |
CERVICITIS |
16 |
0.0359 |
| 154 |
ENCEPHALITIS VIRAL |
43 |
0.0353 |
| 155 |
LIVER TRANSPLANT REJECTION |
63 |
0.0350 |
| 156 |
ADRENAL MASS |
29 |
0.0349 |
| 157 |
DISSEMINATED CRYPTOCOCCOSIS |
26 |
0.0343 |
| 158 |
CRYPTOSPORIDIOSIS INFECTION |
18 |
0.0343 |
| 159 |
PNEUMONIA NECROTISING |
22 |
0.0340 |
| 160 |
PNEUMONIA PSEUDOMONAL |
52 |
0.0339 |
| 161 |
THROMBOTIC MICROANGIOPATHY |
329 |
0.0337 |
| 162 |
GASTROENTERITIS ESCHERICHIA COLI |
18 |
0.0329 |
| 163 |
RETINAL ISCHAEMIA |
20 |
0.0327 |
| 164 |
BRONCHOPULMONARY ASPERGILLOSIS |
253 |
0.0326 |
| 165 |
IMMUNOSUPPRESSANT DRUG LEVEL DECREASED |
39 |
0.0325 |
| 166 |
ENCEPHALITIS HERPES |
16 |
0.0324 |
| 167 |
INCISION SITE PAIN |
38 |
0.0323 |
| 168 |
VARICELLA ZOSTER VIRUS INFECTION |
67 |
0.0323 |
| 169 |
HUMAN HERPESVIRUS 6 INFECTION |
61 |
0.0322 |
| 170 |
RENAL TUBULAR INJURY |
39 |
0.0321 |
| 171 |
CORYNEBACTERIUM INFECTION |
17 |
0.0318 |
| 172 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
316 |
0.0314 |
| 173 |
OPHTHALMIC HERPES SIMPLEX |
18 |
0.0312 |
| 174 |
CAROTID ARTERIOSCLEROSIS |
32 |
0.0310 |
| 175 |
NEPHROPATHY TOXIC |
347 |
0.0309 |
| 176 |
KIDNEY FIBROSIS |
53 |
0.0305 |
| 177 |
SUPERINFECTION BACTERIAL |
24 |
0.0303 |
| 178 |
BACTERIURIA |
17 |
0.0301 |
| 179 |
RED BLOOD CELLS URINE POSITIVE |
29 |
0.0300 |
| 180 |
HEPATITIS VIRAL |
24 |
0.0299 |
| 181 |
INTERVERTEBRAL DISC SPACE NARROWING |
24 |
0.0298 |
| 182 |
ARTERIAL HAEMORRHAGE |
34 |
0.0297 |
| 183 |
APLASIA PURE RED CELL |
102 |
0.0296 |
| 184 |
COLON INJURY |
17 |
0.0296 |
| 185 |
BRONCHOSTENOSIS |
16 |
0.0293 |
| 186 |
ENTEROCOCCAL BACTERAEMIA |
31 |
0.0292 |
| 187 |
HEART TRANSPLANT REJECTION |
30 |
0.0289 |
| 188 |
TRACHEOBRONCHITIS |
22 |
0.0286 |
| 189 |
PNEUMONIA CRYPTOCOCCAL |
27 |
0.0286 |
| 190 |
CARDIAC INFECTION |
21 |
0.0280 |
| 191 |
TERMINAL ILEITIS |
17 |
0.0277 |
| 192 |
CHRONIC GRAFT VERSUS HOST DISEASE |
100 |
0.0277 |
| 193 |
ASPERGILLOSIS |
36 |
0.0275 |
| 194 |
RECTAL PROLAPSE |
33 |
0.0273 |
| 195 |
INTUSSUSCEPTION |
26 |
0.0272 |
| 196 |
BONE MARROW TOXICITY |
32 |
0.0270 |
| 197 |
PSEUDOMONAL BACTERAEMIA |
23 |
0.0269 |
| 198 |
OBLITERATIVE BRONCHIOLITIS |
35 |
0.0267 |
| 199 |
KLEBSIELLA SEPSIS |
30 |
0.0266 |
| 200 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
132 |
0.0265 |
| 201 |
STREPTOCOCCAL BACTERAEMIA |
28 |
0.0257 |
| 202 |
IMMUNE RECONSTITUTION SYNDROME |
33 |
0.0256 |
| 203 |
METAPNEUMOVIRUS INFECTION |
20 |
0.0255 |
| 204 |
BACTERIAL SEPSIS |
83 |
0.0255 |
| 205 |
AORTIC DILATATION |
28 |
0.0252 |
| 206 |
GRAFT VERSUS HOST DISEASE IN LIVER |
18 |
0.0251 |
| 207 |
PARAINFLUENZAE VIRUS INFECTION |
38 |
0.0250 |
| 208 |
SYSTEMIC MYCOSIS |
29 |
0.0248 |
| 209 |
CHORIORETINITIS |
16 |
0.0248 |
| 210 |
PSEUDOMONAS INFECTION |
212 |
0.0247 |
| 211 |
ACTINIC KERATOSIS |
64 |
0.0246 |
| 212 |
ANAL ULCER |
20 |
0.0245 |
| 213 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
65 |
0.0242 |
| 214 |
SEPTIC EMBOLUS |
20 |
0.0240 |
| 215 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
22 |
0.0238 |
| 216 |
PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL |
20 |
0.0237 |
| 217 |
RENAL VEIN THROMBOSIS |
16 |
0.0237 |
| 218 |
BRAIN HERNIATION |
70 |
0.0234 |
| 219 |
ANISOCYTOSIS |
15 |
0.0228 |
| 220 |
HAEMOLYTIC URAEMIC SYNDROME |
52 |
0.0224 |
| 221 |
SYSTEMIC CANDIDA |
56 |
0.0223 |
| 222 |
ESCHERICHIA INFECTION |
183 |
0.0222 |
| 223 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
626 |
0.0221 |
| 224 |
CAMPYLOBACTER INFECTION |
18 |
0.0217 |
| 225 |
ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION |
20 |
0.0216 |
| 226 |
PNEUMONIA FUNGAL |
83 |
0.0210 |
| 227 |
MENINGITIS VIRAL |
28 |
0.0204 |
| 228 |
FUNGAEMIA |
32 |
0.0203 |
| 229 |
HEPATOSPLENOMEGALY |
51 |
0.0199 |
| 230 |
ENTEROBACTER INFECTION |
33 |
0.0196 |
| 231 |
LEUKOPENIA |
976 |
0.0195 |
| 232 |
VENOOCCLUSIVE LIVER DISEASE |
96 |
0.0194 |
| 233 |
BICYTOPENIA |
38 |
0.0194 |
| 234 |
RETINAL VASCULITIS |
23 |
0.0193 |
| 235 |
URINARY TRACT INFECTION ENTEROCOCCAL |
18 |
0.0193 |
| 236 |
KLEBSIELLA BACTERAEMIA |
18 |
0.0189 |
| 237 |
LYMPHOPENIA |
267 |
0.0189 |
| 238 |
VIRAL LOAD INCREASED |
73 |
0.0188 |
| 239 |
NEUROLOGICAL DECOMPENSATION |
43 |
0.0186 |
| 240 |
RETINITIS |
32 |
0.0185 |
| 241 |
MENINGITIS CRYPTOCOCCAL |
32 |
0.0183 |
| 242 |
DIFFUSE ALVEOLAR DAMAGE |
21 |
0.0183 |
| 243 |
PNEUMONIA PNEUMOCOCCAL |
27 |
0.0182 |
| 244 |
HYPOGAMMAGLOBULINAEMIA |
117 |
0.0178 |
| 245 |
NEPHROGENIC DIABETES INSIPIDUS |
20 |
0.0173 |
| 246 |
SECONDARY IMMUNODEFICIENCY |
21 |
0.0173 |
| 247 |
PANCYTOPENIA |
960 |
0.0172 |
| 248 |
ESCHERICHIA BACTERAEMIA |
40 |
0.0170 |
| 249 |
PNEUMONIA KLEBSIELLA |
31 |
0.0168 |
| 250 |
ORCHITIS |
18 |
0.0167 |
| 251 |
STEROID DIABETES |
25 |
0.0167 |
| 252 |
CYTOPENIA |
203 |
0.0166 |
| 253 |
ESCHERICHIA SEPSIS |
48 |
0.0165 |
| 254 |
NEUTROPENIC COLITIS |
34 |
0.0164 |
| 255 |
PNEUMONIA STREPTOCOCCAL |
18 |
0.0164 |
| 256 |
RENAL TUBULAR NECROSIS |
161 |
0.0164 |
| 257 |
VENOOCCLUSIVE DISEASE |
41 |
0.0164 |
| 258 |
GENE MUTATION |
32 |
0.0162 |
| 259 |
ILEAL ULCER |
16 |
0.0158 |
| 260 |
INFECTIOUS PLEURAL EFFUSION |
24 |
0.0158 |
| 261 |
RHINOVIRUS INFECTION |
61 |
0.0157 |
| 262 |
CANDIDA INFECTION |
264 |
0.0156 |
| 263 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
149 |
0.0156 |
| 264 |
PYELONEPHRITIS ACUTE |
30 |
0.0153 |
| 265 |
DISSEMINATED TUBERCULOSIS |
39 |
0.0152 |
| 266 |
STAPHYLOCOCCAL SEPSIS |
75 |
0.0152 |
| 267 |
MULTIPLE-DRUG RESISTANCE |
47 |
0.0151 |
| 268 |
LYMPHADENOPATHY MEDIASTINAL |
29 |
0.0151 |
| 269 |
ORGANISING PNEUMONIA |
75 |
0.0151 |
| 270 |
CLOSTRIDIUM DIFFICILE COLITIS |
160 |
0.0151 |
| 271 |
SQUAMOUS CELL CARCINOMA OF SKIN |
91 |
0.0151 |
| 272 |
OESOPHAGEAL CANDIDIASIS |
60 |
0.0150 |
| 273 |
NORMOCHROMIC NORMOCYTIC ANAEMIA |
45 |
0.0150 |
| 274 |
HYDRONEPHROSIS |
111 |
0.0148 |
| 275 |
HYPERPARATHYROIDISM SECONDARY |
37 |
0.0148 |
| 276 |
VIRAL MUTATION IDENTIFIED |
54 |
0.0146 |
| 277 |
URINARY TRACT INFECTION BACTERIAL |
37 |
0.0146 |
| 278 |
ACUTE LUNG INJURY |
17 |
0.0143 |
| 279 |
LUNG ABSCESS |
30 |
0.0143 |
| 280 |
ATYPICAL MYCOBACTERIAL INFECTION |
20 |
0.0141 |
| 281 |
AORTIC ARTERIOSCLEROSIS |
36 |
0.0140 |
| 282 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
37 |
0.0139 |
| 283 |
RENAL TUBULAR DISORDER |
39 |
0.0138 |
| 284 |
STAPHYLOCOCCAL SKIN INFECTION |
17 |
0.0138 |
| 285 |
HERPES SIMPLEX |
89 |
0.0137 |
| 286 |
SEPTIC SHOCK |
595 |
0.0137 |
| 287 |
HYPERURICAEMIA |
56 |
0.0136 |
| 288 |
PNEUMONIA INFLUENZAL |
16 |
0.0134 |
| 289 |
MYCOBACTERIAL INFECTION |
23 |
0.0133 |
| 290 |
STAPHYLOCOCCAL BACTERAEMIA |
58 |
0.0133 |
| 291 |
AGRANULOCYTOSIS |
248 |
0.0133 |
| 292 |
HEPATIC INFECTION |
17 |
0.0133 |
| 293 |
MEAN CELL VOLUME INCREASED |
34 |
0.0132 |
| 294 |
CLOSTRIDIUM COLITIS |
16 |
0.0132 |
| 295 |
ESCHERICHIA URINARY TRACT INFECTION |
56 |
0.0132 |
| 296 |
HYPERPARATHYROIDISM |
27 |
0.0131 |
| 297 |
BACTERAEMIA |
155 |
0.0130 |
| 298 |
LARGE INTESTINAL ULCER |
35 |
0.0129 |
| 299 |
PNEUMONIA BACTERIAL |
117 |
0.0127 |
| 300 |
GLOMERULONEPHRITIS |
31 |
0.0127 |
| 301 |
PNEUMONIA VIRAL |
40 |
0.0125 |
| 302 |
PSEUDOMEMBRANOUS COLITIS |
28 |
0.0125 |
| 303 |
BILE DUCT STENOSIS |
15 |
0.0125 |
| 304 |
BONE MARROW FAILURE |
254 |
0.0125 |
| 305 |
NOROVIRUS INFECTION |
18 |
0.0125 |
| 306 |
HYPERLACTACIDAEMIA |
33 |
0.0123 |
| 307 |
NOSOCOMIAL INFECTION |
27 |
0.0122 |
| 308 |
NORMOCYTIC ANAEMIA |
18 |
0.0122 |
| 309 |
HYPERAMMONAEMIA |
61 |
0.0122 |
| 310 |
PNEUMOMEDIASTINUM |
22 |
0.0122 |
| 311 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
100 |
0.0121 |
| 312 |
HYPOPROTEINAEMIA |
23 |
0.0121 |
| 313 |
SHOCK HAEMORRHAGIC |
98 |
0.0120 |
| 314 |
LEFT VENTRICULAR HYPERTROPHY |
51 |
0.0119 |
| 315 |
APLASTIC ANAEMIA |
62 |
0.0119 |
| 316 |
LEUKAEMIA RECURRENT |
20 |
0.0118 |
| 317 |
ENCEPHALITIS |
81 |
0.0117 |
| 318 |
LIVER ABSCESS |
37 |
0.0114 |
| 319 |
LUNG TRANSPLANT |
40 |
0.0113 |
| 320 |
HIRSUTISM |
15 |
0.0113 |
| 321 |
LYMPHOPROLIFERATIVE DISORDER |
33 |
0.0112 |
| 322 |
CD4 LYMPHOCYTES DECREASED |
24 |
0.0112 |
| 323 |
HISTIOCYTOSIS HAEMATOPHAGIC |
33 |
0.0111 |
| 324 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
196 |
0.0111 |
| 325 |
RENAL TRANSPLANT |
40 |
0.0111 |
| 326 |
RENAL TUBULAR ACIDOSIS |
24 |
0.0110 |
| 327 |
VASCULAR PSEUDOANEURYSM |
19 |
0.0109 |
| 328 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
24 |
0.0108 |
| 329 |
OLIGURIA |
66 |
0.0106 |
| 330 |
FUNGAL SKIN INFECTION |
42 |
0.0104 |
| 331 |
GASTROINTESTINAL ULCER |
23 |
0.0104 |
| 332 |
IMMUNE THROMBOCYTOPENIA |
46 |
0.0100 |
| 333 |
MYELOSUPPRESSION |
361 |
0.0100 |
| 334 |
RETROPERITONEAL HAEMATOMA |
22 |
0.0099 |
| 335 |
PYELONEPHRITIS |
86 |
0.0099 |
| 336 |
END STAGE RENAL DISEASE |
181 |
0.0099 |
| 337 |
OESOPHAGEAL ULCER |
38 |
0.0099 |
| 338 |
GRANULOMA |
34 |
0.0098 |
| 339 |
HEPATIC NECROSIS |
37 |
0.0098 |
| 340 |
HAEMATOLOGICAL INFECTION |
24 |
0.0098 |
| 341 |
NEUTROPENIA |
1333 |
0.0098 |
| 342 |
OPPORTUNISTIC INFECTION |
18 |
0.0097 |
| 343 |
GUILLAIN-BARRE SYNDROME |
47 |
0.0097 |
| 344 |
CAPILLARY LEAK SYNDROME |
20 |
0.0097 |
| 345 |
FIBRIN D DIMER INCREASED |
34 |
0.0096 |
| 346 |
HEPATITIS E |
15 |
0.0095 |
| 347 |
HISTOPLASMOSIS DISSEMINATED |
15 |
0.0094 |
| 348 |
DEVICE RELATED SEPSIS |
19 |
0.0094 |
| 349 |
VITREOUS HAEMORRHAGE |
26 |
0.0094 |
| 350 |
HEPATITIS CHOLESTATIC |
55 |
0.0091 |
| 351 |
RESPIRATORY FAILURE |
662 |
0.0091 |
| 352 |
LIVER TRANSPLANT |
33 |
0.0091 |
| 353 |
INFECTED SKIN ULCER |
17 |
0.0090 |
| 354 |
HYPERCAPNIA |
27 |
0.0090 |
| 355 |
ENTEROCOLITIS |
51 |
0.0088 |
| 356 |
LUNG INFILTRATION |
78 |
0.0088 |
| 357 |
PULMONARY TUBERCULOSIS |
37 |
0.0087 |
| 358 |
ABDOMINAL INFECTION |
22 |
0.0086 |
| 359 |
DISSEMINATED INTRAVASCULAR COAGULATION |
121 |
0.0086 |
| 360 |
ODYNOPHAGIA |
51 |
0.0085 |
| 361 |
ANAEMIA MACROCYTIC |
18 |
0.0084 |
| 362 |
HAEMATOTOXICITY |
79 |
0.0083 |
| 363 |
PULMONARY HAEMORRHAGE |
65 |
0.0083 |
| 364 |
RENAL IMPAIRMENT |
693 |
0.0082 |
| 365 |
DIVERTICULUM INTESTINAL |
36 |
0.0082 |
| 366 |
DIFFUSE LARGE B-CELL LYMPHOMA |
63 |
0.0082 |
| 367 |
WOUND COMPLICATION |
28 |
0.0082 |
| 368 |
ABDOMINAL ABSCESS |
36 |
0.0081 |
| 369 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
31 |
0.0081 |
| 370 |
PARESIS |
18 |
0.0081 |
| 371 |
DRUG LEVEL INCREASED |
132 |
0.0080 |
| 372 |
THROMBOCYTOSIS |
29 |
0.0079 |
| 373 |
BENIGN PROSTATIC HYPERPLASIA |
40 |
0.0077 |
| 374 |
HYPERVOLAEMIA |
38 |
0.0077 |
| 375 |
PULMONARY ALVEOLAR HAEMORRHAGE |
43 |
0.0077 |
| 376 |
COVID-19 PNEUMONIA |
90 |
0.0076 |
| 377 |
ENDOCARDITIS |
39 |
0.0076 |
| 378 |
LUNG OPACITY |
20 |
0.0076 |
| 379 |
HAEMORRHAGE INTRACRANIAL |
113 |
0.0075 |
| 380 |
HYDROCEPHALUS |
41 |
0.0075 |
| 381 |
MULTI-ORGAN FAILURE |
130 |
0.0075 |
| 382 |
SPINAL STENOSIS |
31 |
0.0075 |
| 383 |
HAEMODYNAMIC INSTABILITY |
57 |
0.0075 |
| 384 |
STUPOR |
24 |
0.0075 |
| 385 |
BACTERIAL INFECTION |
138 |
0.0074 |
| 386 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
26 |
0.0074 |
| 387 |
HYPOPHOSPHATAEMIA |
54 |
0.0073 |
| 388 |
RESPIRATORY TRACT INFECTION VIRAL |
17 |
0.0073 |
| 389 |
RESPIRATORY DISTRESS |
200 |
0.0072 |
| 390 |
INTRAVENTRICULAR HAEMORRHAGE |
18 |
0.0072 |
| 391 |
ORAL CANDIDIASIS |
95 |
0.0072 |
| 392 |
DRUG LEVEL ABOVE THERAPEUTIC |
33 |
0.0072 |
| 393 |
CACHEXIA |
37 |
0.0072 |
| 394 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
36 |
0.0071 |
| 395 |
TUBULOINTERSTITIAL NEPHRITIS |
133 |
0.0071 |
| 396 |
PROTEIN URINE PRESENT |
35 |
0.0070 |
| 397 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
15 |
0.0070 |
| 398 |
LEUKOENCEPHALOPATHY |
26 |
0.0070 |
| 399 |
GENERALISED OEDEMA |
86 |
0.0069 |
| 400 |
BRAIN OEDEMA |
87 |
0.0069 |
| 401 |
GASTROINTESTINAL NECROSIS |
20 |
0.0069 |
| 402 |
SERUM SICKNESS |
19 |
0.0068 |
| 403 |
HYPOALBUMINAEMIA |
53 |
0.0068 |
| 404 |
HAEMOLYTIC ANAEMIA |
61 |
0.0068 |
| 405 |
CHOLESTATIC LIVER INJURY |
15 |
0.0067 |
| 406 |
CYTOKINE RELEASE SYNDROME |
135 |
0.0067 |
| 407 |
CHOLESTASIS |
129 |
0.0067 |
| 408 |
MIXED LIVER INJURY |
20 |
0.0066 |
| 409 |
THROMBOCYTOPENIA |
743 |
0.0066 |
| 410 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
40 |
0.0066 |
| 411 |
HYPERBILIRUBINAEMIA |
68 |
0.0066 |
| 412 |
WOUND DEHISCENCE |
22 |
0.0065 |
| 413 |
SPLENOMEGALY |
76 |
0.0065 |
| 414 |
RETINAL HAEMORRHAGE |
46 |
0.0065 |
| 415 |
RETINAL DETACHMENT |
59 |
0.0064 |
| 416 |
GASTROINTESTINAL STROMAL TUMOUR |
17 |
0.0064 |
| 417 |
GASTRIC ULCER |
121 |
0.0064 |
| 418 |
SEPSIS |
706 |
0.0063 |
| 419 |
OESOPHAGEAL STENOSIS |
18 |
0.0063 |
| 420 |
FUNGAL INFECTION |
208 |
0.0062 |
| 421 |
B-CELL LYMPHOMA |
21 |
0.0062 |
| 422 |
FIBROSIS |
19 |
0.0062 |
| 423 |
FEBRILE NEUTROPENIA |
407 |
0.0061 |
| 424 |
ASCITES |
180 |
0.0061 |
| 425 |
IMMUNOSUPPRESSION |
54 |
0.0061 |
| 426 |
FEBRILE BONE MARROW APLASIA |
26 |
0.0061 |
| 427 |
AORTIC VALVE INCOMPETENCE |
26 |
0.0061 |
| 428 |
BLOOD CREATININE INCREASED |
397 |
0.0061 |
| 429 |
LUNG CONSOLIDATION |
17 |
0.0061 |
| 430 |
ENCEPHALOPATHY |
149 |
0.0061 |
| 431 |
GASTROINTESTINAL TOXICITY |
29 |
0.0060 |
| 432 |
ACUTE RESPIRATORY FAILURE |
116 |
0.0060 |
| 433 |
ATYPICAL PNEUMONIA |
18 |
0.0060 |
| 434 |
LYMPHOCYTE COUNT DECREASED |
106 |
0.0060 |
| 435 |
ACUTE KIDNEY INJURY |
905 |
0.0059 |
| 436 |
HYPOMAGNESAEMIA |
82 |
0.0059 |
| 437 |
MACULAR OEDEMA |
33 |
0.0059 |
| 438 |
DUODENITIS |
18 |
0.0059 |
| 439 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
20 |
0.0058 |
| 440 |
BRAIN DEATH |
18 |
0.0058 |
| 441 |
MALNUTRITION |
65 |
0.0058 |
| 442 |
ENTERITIS |
37 |
0.0058 |
| 443 |
COLITIS |
217 |
0.0057 |
| 444 |
ORGAN FAILURE |
23 |
0.0057 |
| 445 |
PNEUMOTHORAX |
90 |
0.0057 |
| 446 |
TOXIC EPIDERMAL NECROLYSIS |
86 |
0.0057 |
| 447 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
58 |
0.0056 |
| 448 |
UROSEPSIS |
52 |
0.0056 |
| 449 |
CLOSTRIDIAL INFECTION |
19 |
0.0056 |
| 450 |
HYPERKALAEMIA |
196 |
0.0056 |
| 451 |
ANURIA |
48 |
0.0056 |
| 452 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
33 |
0.0056 |
| 453 |
STAPHYLOCOCCAL INFECTION |
183 |
0.0055 |
| 454 |
SHOCK |
127 |
0.0055 |
| 455 |
GASTRIC PERFORATION |
15 |
0.0055 |
| 456 |
CANDIDIASIS |
22 |
0.0055 |
| 457 |
HYPERTRANSAMINASAEMIA |
38 |
0.0055 |
| 458 |
OTITIS MEDIA |
18 |
0.0054 |
| 459 |
METABOLIC ACIDOSIS |
174 |
0.0054 |
| 460 |
HYPERCALCAEMIA |
67 |
0.0054 |
| 461 |
DIARRHOEA HAEMORRHAGIC |
50 |
0.0053 |
| 462 |
ELECTROLYTE IMBALANCE |
62 |
0.0053 |
| 463 |
HIV INFECTION |
16 |
0.0053 |
| 464 |
LUNG INFECTION |
82 |
0.0053 |
| 465 |
URINE OUTPUT DECREASED |
46 |
0.0053 |
| 466 |
HYPERNATRAEMIA |
26 |
0.0052 |
| 467 |
SUBCUTANEOUS ABSCESS |
25 |
0.0052 |
| 468 |
BRONCHIECTASIS |
35 |
0.0052 |
| 469 |
PORTAL HYPERTENSION |
16 |
0.0052 |
| 470 |
LARGE INTESTINE PERFORATION |
36 |
0.0052 |
| 471 |
ENDOPHTHALMITIS |
31 |
0.0052 |
| 472 |
TOXIC ENCEPHALOPATHY |
26 |
0.0051 |
| 473 |
SUSPECTED OFF LABEL USE |
23 |
0.0051 |
| 474 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
277 |
0.0050 |
| 475 |
NEUTROPHIL COUNT INCREASED |
51 |
0.0050 |
| 476 |
NEPHROGENIC ANAEMIA |
23 |
0.0050 |
| 477 |
HYPERTRIGLYCERIDAEMIA |
29 |
0.0049 |
| 478 |
C-REACTIVE PROTEIN INCREASED |
178 |
0.0049 |
| 479 |
POSTOPERATIVE WOUND INFECTION |
33 |
0.0049 |
| 480 |
HEPATOMEGALY |
48 |
0.0049 |
| 481 |
MYOPATHY |
42 |
0.0049 |
| 482 |
NEUROTOXICITY |
85 |
0.0048 |
| 483 |
HEPATIC FAILURE |
146 |
0.0048 |
| 484 |
BLOOD UREA INCREASED |
80 |
0.0048 |
| 485 |
CEREBRAL HAEMATOMA |
16 |
0.0048 |
| 486 |
HEPATOCELLULAR INJURY |
67 |
0.0047 |
| 487 |
TACHYPNOEA |
64 |
0.0047 |
| 488 |
PNEUMONITIS |
128 |
0.0047 |
| 489 |
INTRACRANIAL PRESSURE INCREASED |
26 |
0.0047 |
| 490 |
PRE-ECLAMPSIA |
22 |
0.0046 |
| 491 |
SWELLING OF EYELID |
29 |
0.0046 |
| 492 |
BASAL CELL CARCINOMA |
72 |
0.0046 |
| 493 |
PLEURAL EFFUSION |
279 |
0.0046 |
| 494 |
ACIDOSIS |
35 |
0.0046 |
| 495 |
CARDIAC DYSFUNCTION |
17 |
0.0046 |
| 496 |
NEUROLOGICAL SYMPTOM |
26 |
0.0045 |
| 497 |
LARGE INTESTINE POLYP |
31 |
0.0045 |
| 498 |
ACUTE HEPATIC FAILURE |
61 |
0.0045 |
| 499 |
GASTROINTESTINAL INFECTION |
40 |
0.0045 |
| 500 |
ABDOMINAL TENDERNESS |
22 |
0.0044 |
| 501 |
VASCULAR DEVICE INFECTION |
20 |
0.0044 |
| 502 |
TONSILLITIS |
23 |
0.0044 |
| 503 |
HYPOXIA |
155 |
0.0044 |
| 504 |
PLEURISY |
26 |
0.0044 |
| 505 |
TUMOUR LYSIS SYNDROME |
38 |
0.0043 |
| 506 |
GASTROENTERITIS |
63 |
0.0043 |
| 507 |
MUCOSAL INFLAMMATION |
113 |
0.0043 |
| 508 |
HEPATIC CYTOLYSIS |
55 |
0.0043 |
| 509 |
NECROSIS |
24 |
0.0043 |
| 510 |
CLOSTRIDIUM DIFFICILE INFECTION |
94 |
0.0043 |
| 511 |
BLOOD CREATINE INCREASED |
19 |
0.0043 |
| 512 |
RENAL CYST |
34 |
0.0043 |
| 513 |
HAEMOLYSIS |
33 |
0.0043 |
| 514 |
PROTEINURIA |
81 |
0.0043 |
| 515 |
HEMIPARESIS |
72 |
0.0042 |
| 516 |
HEPATITIS |
108 |
0.0042 |
| 517 |
HERPES VIRUS INFECTION |
24 |
0.0042 |
| 518 |
RASH MACULO-PAPULAR |
92 |
0.0041 |
| 519 |
DRUG LEVEL DECREASED |
42 |
0.0041 |
| 520 |
FOETAL GROWTH RESTRICTION |
25 |
0.0041 |
| 521 |
HYPOVOLAEMIA |
24 |
0.0041 |
| 522 |
AMYLASE INCREASED |
15 |
0.0041 |
| 523 |
HAEMODIALYSIS |
34 |
0.0040 |
| 524 |
ARTERIOSCLEROSIS |
38 |
0.0040 |
| 525 |
CHOLANGITIS |
25 |
0.0040 |
| 526 |
DEVICE RELATED INFECTION |
62 |
0.0040 |
| 527 |
HEPATIC FUNCTION ABNORMAL |
150 |
0.0040 |
| 528 |
HYPERLIPIDAEMIA |
48 |
0.0040 |
| 529 |
SKIN PAPILLOMA |
16 |
0.0040 |
| 530 |
SPINAL OSTEOARTHRITIS |
35 |
0.0040 |
| 531 |
INTERSTITIAL LUNG DISEASE |
192 |
0.0040 |
| 532 |
PULMONARY MASS |
59 |
0.0040 |
| 533 |
HEPATIC LESION |
17 |
0.0039 |
| 534 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
17 |
0.0039 |
| 535 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
62 |
0.0039 |
| 536 |
OFF LABEL USE |
3421 |
0.0039 |
| 537 |
ONYCHOMYCOSIS |
17 |
0.0039 |
| 538 |
NEPHROPATHY |
36 |
0.0039 |
| 539 |
PRODUCT USE IN UNAPPROVED INDICATION |
954 |
0.0038 |
| 540 |
ANAEMIA |
728 |
0.0038 |
| 541 |
LEUKOCYTOSIS |
68 |
0.0038 |
| 542 |
DYSLIPIDAEMIA |
19 |
0.0037 |
| 543 |
CENTRAL NERVOUS SYSTEM LESION |
51 |
0.0037 |
| 544 |
BUNDLE BRANCH BLOCK RIGHT |
17 |
0.0037 |
| 545 |
FAILURE TO THRIVE |
19 |
0.0037 |
| 546 |
DRUG LEVEL BELOW THERAPEUTIC |
20 |
0.0036 |
| 547 |
RALES |
21 |
0.0036 |
| 548 |
ASPIRATION |
39 |
0.0036 |
| 549 |
RENAL FAILURE |
472 |
0.0036 |
| 550 |
HEPATOTOXICITY |
79 |
0.0035 |
| 551 |
BLOOD ALBUMIN DECREASED |
28 |
0.0035 |
| 552 |
MENTAL STATUS CHANGES |
98 |
0.0035 |
| 553 |
FACIAL PARALYSIS |
30 |
0.0035 |
| 554 |
NEUTROPENIC SEPSIS |
25 |
0.0035 |
| 555 |
HYPONATRAEMIA |
197 |
0.0035 |
| 556 |
APHTHOUS ULCER |
27 |
0.0035 |
| 557 |
COAGULOPATHY |
58 |
0.0035 |
| 558 |
UVEITIS |
47 |
0.0035 |
| 559 |
AUTOIMMUNE HEPATITIS |
24 |
0.0034 |
| 560 |
PYREXIA |
1187 |
0.0034 |
| 561 |
CARDIOGENIC SHOCK |
49 |
0.0034 |
| 562 |
ORAL DISORDER |
25 |
0.0034 |
| 563 |
HAEMATURIA |
116 |
0.0034 |
| 564 |
NEPHROTIC SYNDROME |
23 |
0.0034 |
| 565 |
MYOCLONUS |
40 |
0.0034 |
| 566 |
SUBARACHNOID HAEMORRHAGE |
34 |
0.0033 |
| 567 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
29 |
0.0033 |
| 568 |
ABSCESS |
53 |
0.0033 |
| 569 |
INTENTIONAL PRODUCT USE ISSUE |
290 |
0.0033 |
| 570 |
CEREBRAL ISCHAEMIA |
17 |
0.0033 |
| 571 |
POLYURIA |
27 |
0.0033 |
| 572 |
MENINGITIS |
22 |
0.0033 |
| 573 |
LEFT VENTRICULAR DYSFUNCTION |
22 |
0.0033 |
| 574 |
SKIN NECROSIS |
17 |
0.0033 |
| 575 |
THERAPY NON-RESPONDER |
146 |
0.0032 |
| 576 |
INTESTINAL PERFORATION |
36 |
0.0032 |
| 577 |
MOUTH ULCERATION |
67 |
0.0032 |
| 578 |
HEPATITIS B |
19 |
0.0031 |
| 579 |
LOW BIRTH WEIGHT BABY |
25 |
0.0031 |
| 580 |
BLOOD POTASSIUM INCREASED |
51 |
0.0031 |
| 581 |
MYOCARDITIS |
36 |
0.0031 |
| 582 |
NEUTROPHIL COUNT DECREASED |
128 |
0.0031 |
| 583 |
ADRENAL INSUFFICIENCY |
38 |
0.0031 |
| 584 |
LYMPHOMA |
48 |
0.0031 |
| 585 |
WOUND INFECTION |
34 |
0.0031 |
| 586 |
RENAL FAILURE ACUTE |
131 |
0.0031 |
| 587 |
GENERALISED TONIC-CLONIC SEIZURE |
51 |
0.0031 |
| 588 |
BLOOD LACTIC ACID INCREASED |
16 |
0.0030 |
| 589 |
ATAXIA |
36 |
0.0030 |
| 590 |
PERICARDIAL EFFUSION |
70 |
0.0030 |
| 591 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
67 |
0.0030 |
| 592 |
LYMPHADENOPATHY |
107 |
0.0030 |
| 593 |
DRUG INTERACTION |
478 |
0.0030 |
| 594 |
ATELECTASIS |
29 |
0.0030 |
| 595 |
GRANULOCYTOPENIA |
17 |
0.0030 |
| 596 |
ATRIOVENTRICULAR BLOCK |
23 |
0.0030 |
| 597 |
HYPERGLYCAEMIA |
108 |
0.0030 |
| 598 |
HYPOKALAEMIA |
136 |
0.0029 |
| 599 |
TRANSAMINASES INCREASED |
65 |
0.0029 |
| 600 |
STATUS EPILEPTICUS |
33 |
0.0029 |
| 601 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
75 |
0.0029 |
| 602 |
PERIPHERAL SENSORY NEUROPATHY |
17 |
0.0029 |
| 603 |
DRUG-INDUCED LIVER INJURY |
90 |
0.0029 |
| 604 |
LEUKAEMIA |
27 |
0.0029 |
| 605 |
LIVER FUNCTION TEST ABNORMAL |
83 |
0.0029 |
| 606 |
PERITONITIS |
59 |
0.0028 |
| 607 |
PAPULE |
20 |
0.0028 |
| 608 |
FOREIGN BODY SENSATION IN EYES |
18 |
0.0028 |
| 609 |
VITAMIN D DECREASED |
24 |
0.0028 |
| 610 |
HAEMOGLOBIN DECREASED |
287 |
0.0028 |
| 611 |
CEREBRAL HAEMORRHAGE |
100 |
0.0028 |
| 612 |
BLOOD BILIRUBIN INCREASED |
75 |
0.0028 |
| 613 |
PNEUMONIA ASPIRATION |
69 |
0.0028 |
| 614 |
LIVE BIRTH |
23 |
0.0027 |
| 615 |
BLOOD DISORDER |
22 |
0.0027 |
| 616 |
EOSINOPHILIA |
48 |
0.0027 |
| 617 |
HEPATITIS C |
33 |
0.0027 |
| 618 |
GLOMERULAR FILTRATION RATE DECREASED |
33 |
0.0027 |
| 619 |
SKIN LESION |
73 |
0.0027 |
| 620 |
HEPATIC STEATOSIS |
49 |
0.0026 |
| 621 |
VIRAL INFECTION |
87 |
0.0026 |
| 622 |
LIVER INJURY |
64 |
0.0026 |
| 623 |
LUNG DISORDER |
127 |
0.0026 |
| 624 |
GASTRITIS |
68 |
0.0026 |
| 625 |
ILEUS |
32 |
0.0026 |
| 626 |
TREATMENT FAILURE |
213 |
0.0026 |
| 627 |
MYOSITIS |
23 |
0.0026 |
| 628 |
WHITE BLOOD CELL COUNT INCREASED |
98 |
0.0026 |
| 629 |
DUODENAL ULCER |
18 |
0.0025 |
| 630 |
PULMONARY HYPERTENSION |
53 |
0.0025 |
| 631 |
INFUSION SITE SWELLING |
16 |
0.0025 |
| 632 |
TERMINAL STATE |
17 |
0.0025 |
| 633 |
ALTERED STATE OF CONSCIOUSNESS |
55 |
0.0025 |
| 634 |
RESPIRATORY TRACT INFECTION |
66 |
0.0025 |
| 635 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
99 |
0.0025 |
| 636 |
HEPATOCELLULAR CARCINOMA |
19 |
0.0025 |
| 637 |
SKIN INFECTION |
28 |
0.0025 |
| 638 |
FAECES SOFT |
18 |
0.0025 |
| 639 |
PNEUMONIA |
798 |
0.0025 |
| 640 |
DECUBITUS ULCER |
20 |
0.0025 |
| 641 |
COLITIS ULCERATIVE |
109 |
0.0024 |
| 642 |
PULMONARY OEDEMA |
109 |
0.0024 |
| 643 |
URINARY TRACT INFECTION |
411 |
0.0024 |
| 644 |
ORAL HERPES |
47 |
0.0024 |
| 645 |
SUPRAVENTRICULAR TACHYCARDIA |
23 |
0.0024 |
| 646 |
INFECTION |
347 |
0.0024 |
| 647 |
PHOTOPHOBIA |
45 |
0.0024 |
| 648 |
BLOOD PRESSURE FLUCTUATION |
57 |
0.0024 |
| 649 |
OSTEOMYELITIS |
43 |
0.0024 |
| 650 |
PLATELET COUNT DECREASED |
251 |
0.0024 |
| 651 |
DISEASE RECURRENCE |
112 |
0.0024 |
| 652 |
VISUAL FIELD DEFECT |
17 |
0.0024 |
| 653 |
CARDIAC ARREST |
194 |
0.0023 |
| 654 |
PRODUCT USE ISSUE |
437 |
0.0023 |
| 655 |
HALLUCINATION, VISUAL |
49 |
0.0023 |
| 656 |
HEPATITIS ACUTE |
15 |
0.0023 |
| 657 |
WHITE BLOOD CELL COUNT DECREASED |
249 |
0.0023 |
| 658 |
ALANINE AMINOTRANSFERASE INCREASED |
141 |
0.0023 |
| 659 |
OESOPHAGITIS |
25 |
0.0023 |
| 660 |
PULMONARY TOXICITY |
16 |
0.0023 |
| 661 |
ACUTE MYELOID LEUKAEMIA |
35 |
0.0022 |
| 662 |
METASTASIS |
16 |
0.0022 |
| 663 |
VASCULITIS |
26 |
0.0022 |
| 664 |
TOXICITY TO VARIOUS AGENTS |
373 |
0.0022 |
| 665 |
DIABETES MELLITUS |
168 |
0.0022 |
| 666 |
RESTLESS LEGS SYNDROME |
40 |
0.0022 |
| 667 |
FLUID OVERLOAD |
32 |
0.0022 |
| 668 |
SMALL INTESTINAL OBSTRUCTION |
27 |
0.0022 |
| 669 |
HERPES ZOSTER |
126 |
0.0022 |
| 670 |
HEMIPLEGIA |
18 |
0.0022 |
| 671 |
HAEMORRHOIDS |
42 |
0.0022 |
| 672 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
36 |
0.0021 |
| 673 |
TRICUSPID VALVE INCOMPETENCE |
17 |
0.0021 |
| 674 |
DISEASE PROGRESSION |
253 |
0.0021 |
| 675 |
THERAPY PARTIAL RESPONDER |
33 |
0.0021 |
| 676 |
KIDNEY INFECTION |
41 |
0.0021 |
| 677 |
PULMONARY FIBROSIS |
40 |
0.0021 |
| 678 |
MYELODYSPLASTIC SYNDROME |
30 |
0.0021 |
| 679 |
PANCREATITIS ACUTE |
46 |
0.0020 |
| 680 |
GASTROINTESTINAL INFLAMMATION |
16 |
0.0020 |
| 681 |
CARDIOMYOPATHY |
30 |
0.0020 |
| 682 |
FLANK PAIN |
19 |
0.0020 |
| 683 |
EYE PAIN |
114 |
0.0020 |
| 684 |
BLINDNESS |
82 |
0.0020 |
| 685 |
PREMATURE DELIVERY |
32 |
0.0020 |
| 686 |
HYPOPHAGIA |
51 |
0.0020 |
| 687 |
RED BLOOD CELL COUNT DECREASED |
57 |
0.0020 |
| 688 |
PREMATURE BABY |
60 |
0.0020 |
| 689 |
CONDITION AGGRAVATED |
605 |
0.0020 |
| 690 |
DRUG ERUPTION |
35 |
0.0020 |
| 691 |
PRESYNCOPE |
48 |
0.0020 |
| 692 |
CHRONIC KIDNEY DISEASE |
150 |
0.0020 |
| 693 |
LIVER DISORDER |
87 |
0.0020 |
| 694 |
HAEMATEMESIS |
49 |
0.0019 |
| 695 |
CHOLECYSTITIS |
23 |
0.0019 |
| 696 |
CIRCULATORY COLLAPSE |
32 |
0.0019 |
| 697 |
GASTROINTESTINAL HAEMORRHAGE |
156 |
0.0019 |
| 698 |
UPPER RESPIRATORY TRACT INFECTION |
86 |
0.0019 |
| 699 |
BLOOD MAGNESIUM DECREASED |
16 |
0.0019 |
| 700 |
PERICARDITIS |
31 |
0.0018 |
| 701 |
DRUG INEFFECTIVE |
2427 |
0.0018 |
| 702 |
SINUS TACHYCARDIA |
26 |
0.0018 |
| 703 |
HAEMOPTYSIS |
51 |
0.0018 |
| 704 |
RENAL DISORDER |
85 |
0.0018 |
| 705 |
ULCER |
29 |
0.0018 |
| 706 |
HEPATIC ENCEPHALOPATHY |
17 |
0.0018 |
| 707 |
SKIN ULCER |
47 |
0.0018 |
| 708 |
FOLLICULITIS |
19 |
0.0018 |
| 709 |
ATRIAL FIBRILLATION |
176 |
0.0018 |
| 710 |
PERITONITIS BACTERIAL |
18 |
0.0018 |
| 711 |
FISTULA |
20 |
0.0018 |
| 712 |
HYPOTENSION |
356 |
0.0018 |
| 713 |
DIALYSIS |
25 |
0.0018 |
| 714 |
OEDEMA |
95 |
0.0017 |
| 715 |
JAUNDICE |
47 |
0.0017 |
| 716 |
IMMUNODEFICIENCY |
26 |
0.0017 |
| 717 |
COVID-19 |
306 |
0.0017 |
| 718 |
AUTOIMMUNE DISORDER |
17 |
0.0017 |
| 719 |
CONJUNCTIVITIS |
32 |
0.0017 |
| 720 |
DYSURIA |
63 |
0.0017 |
| 721 |
DELIRIUM |
59 |
0.0017 |
| 722 |
HAEMATOMA |
44 |
0.0017 |
| 723 |
ASPARTATE AMINOTRANSFERASE INCREASED |
90 |
0.0017 |
| 724 |
HYPOCALCAEMIA |
32 |
0.0017 |
| 725 |
BLOOD IRON DECREASED |
20 |
0.0017 |
| 726 |
EYELID PTOSIS |
17 |
0.0017 |
| 727 |
BLOOD TRIGLYCERIDES INCREASED |
29 |
0.0016 |
| 728 |
RESPIRATORY DISORDER |
49 |
0.0016 |
| 729 |
PETECHIAE |
17 |
0.0016 |
| 730 |
ABDOMINAL PAIN |
377 |
0.0016 |
| 731 |
POST PROCEDURAL COMPLICATION |
31 |
0.0016 |
| 732 |
GASTROINTESTINAL DISORDER |
144 |
0.0016 |
| 733 |
TACHYCARDIA |
140 |
0.0016 |
| 734 |
DIARRHOEA |
1014 |
0.0016 |
| 735 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
39 |
0.0016 |
| 736 |
OEDEMA PERIPHERAL |
191 |
0.0016 |
| 737 |
BRADYCARDIA |
83 |
0.0016 |
| 738 |
SCHIZOPHRENIA |
19 |
0.0016 |
| 739 |
APHASIA |
47 |
0.0016 |
| 740 |
THROMBOSIS |
125 |
0.0016 |
| 741 |
REBOUND EFFECT |
17 |
0.0015 |
| 742 |
MELAENA |
33 |
0.0015 |
| 743 |
PANCREATITIS |
79 |
0.0015 |
| 744 |
BLINDNESS UNILATERAL |
21 |
0.0015 |
| 745 |
NEOPLASM |
17 |
0.0015 |
| 746 |
COMA |
70 |
0.0015 |
| 747 |
RHABDOMYOLYSIS |
61 |
0.0015 |
| 748 |
IMPAIRED HEALING |
48 |
0.0015 |
| 749 |
DIABETIC KETOACIDOSIS |
35 |
0.0015 |
| 750 |
CARDIAC FAILURE |
116 |
0.0014 |
| 751 |
STEVENS-JOHNSON SYNDROME |
32 |
0.0014 |
| 752 |
HEPATIC CIRRHOSIS |
27 |
0.0014 |
| 753 |
INFLAMMATION |
74 |
0.0014 |
| 754 |
OCULAR DISCOMFORT |
16 |
0.0014 |
| 755 |
POLYNEUROPATHY |
17 |
0.0014 |
| 756 |
MITRAL VALVE INCOMPETENCE |
16 |
0.0014 |
| 757 |
SUBDURAL HAEMATOMA |
20 |
0.0014 |
| 758 |
PRODUCTIVE COUGH |
66 |
0.0014 |
| 759 |
CARDIO-RESPIRATORY ARREST |
57 |
0.0014 |
| 760 |
CEREBRAL INFARCTION |
33 |
0.0013 |
| 761 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
34 |
0.0013 |
| 762 |
EPILEPSY |
41 |
0.0013 |
| 763 |
OXYGEN SATURATION DECREASED |
75 |
0.0013 |
| 764 |
TREATMENT NONCOMPLIANCE |
73 |
0.0013 |
| 765 |
IMPAIRED GASTRIC EMPTYING |
18 |
0.0013 |
| 766 |
CELLULITIS |
65 |
0.0013 |
| 767 |
URINARY RETENTION |
43 |
0.0013 |
| 768 |
ACUTE MYOCARDIAL INFARCTION |
38 |
0.0013 |
| 769 |
HYPERTENSION |
270 |
0.0013 |
| 770 |
FOETAL EXPOSURE DURING PREGNANCY |
103 |
0.0013 |
| 771 |
HAEMATOCHEZIA |
69 |
0.0012 |
| 772 |
MYDRIASIS |
16 |
0.0012 |
| 773 |
FULL BLOOD COUNT DECREASED |
25 |
0.0012 |
| 774 |
PRESCRIBED OVERDOSE |
24 |
0.0012 |
| 775 |
LACTIC ACIDOSIS |
40 |
0.0012 |
| 776 |
HEPATIC ENZYME INCREASED |
84 |
0.0012 |
| 777 |
CYSTITIS |
39 |
0.0012 |
| 778 |
CARDIOMEGALY |
15 |
0.0012 |
| 779 |
DEEP VEIN THROMBOSIS |
79 |
0.0012 |
| 780 |
CONFUSIONAL STATE |
196 |
0.0012 |
| 781 |
VENTRICULAR TACHYCARDIA |
20 |
0.0012 |
| 782 |
GENERAL PHYSICAL HEALTH DETERIORATION |
139 |
0.0012 |
| 783 |
PULMONARY EMBOLISM |
114 |
0.0012 |
| 784 |
SEROTONIN SYNDROME |
23 |
0.0012 |
| 785 |
DYSPNOEA EXERTIONAL |
45 |
0.0012 |
| 786 |
RENAL INJURY |
35 |
0.0012 |
| 787 |
BODY TEMPERATURE INCREASED |
24 |
0.0012 |
| 788 |
STOMATITIS |
71 |
0.0012 |
| 789 |
DISORIENTATION |
46 |
0.0012 |
| 790 |
HAEMATOCRIT DECREASED |
23 |
0.0012 |
| 791 |
OSTEONECROSIS |
38 |
0.0012 |
| 792 |
PROCEDURAL PAIN |
32 |
0.0012 |
| 793 |
NERVOUS SYSTEM DISORDER |
35 |
0.0011 |
| 794 |
DIPLOPIA |
29 |
0.0011 |
| 795 |
VISUAL ACUITY REDUCED |
37 |
0.0011 |
| 796 |
RASH ERYTHEMATOUS |
53 |
0.0011 |
| 797 |
TREMOR |
184 |
0.0011 |
| 798 |
DRUG TOXICITY |
15 |
0.0011 |
| 799 |
EJECTION FRACTION DECREASED |
17 |
0.0011 |
| 800 |
DECREASED APPETITE |
248 |
0.0011 |
| 801 |
DEHYDRATION |
142 |
0.0011 |
| 802 |
WEIGHT DECREASED |
297 |
0.0011 |
| 803 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
31 |
0.0011 |
| 804 |
MUSCULOSKELETAL DISCOMFORT |
18 |
0.0010 |
| 805 |
FEAR |
28 |
0.0010 |
| 806 |
COUGH |
290 |
0.0010 |
| 807 |
EYE IRRITATION |
59 |
0.0010 |
| 808 |
LIVER FUNCTION TEST INCREASED |
22 |
0.0010 |
| 809 |
DIABETES MELLITUS INADEQUATE CONTROL |
18 |
0.0010 |
| 810 |
OCULAR HYPERAEMIA |
48 |
0.0010 |
| 811 |
GASTROENTERITIS VIRAL |
18 |
0.0010 |
| 812 |
PALLOR |
27 |
0.0010 |
| 813 |
LOWER RESPIRATORY TRACT INFECTION |
45 |
0.0010 |
| 814 |
BLOOD COUNT ABNORMAL |
15 |
0.0010 |
| 815 |
ORTHOSTATIC HYPOTENSION |
17 |
0.0010 |
| 816 |
PHOTOSENSITIVITY REACTION |
16 |
0.0010 |
| 817 |
UNRESPONSIVE TO STIMULI |
25 |
0.0010 |
| 818 |
SEIZURE |
111 |
0.0010 |
| 819 |
LACRIMATION INCREASED |
29 |
0.0010 |
| 820 |
PRESCRIBED UNDERDOSE |
19 |
0.0010 |
| 821 |
DYSPHAGIA |
89 |
0.0009 |
| 822 |
INTERNATIONAL NORMALISED RATIO INCREASED |
26 |
0.0009 |
| 823 |
ABDOMINAL PAIN LOWER |
23 |
0.0009 |
| 824 |
CHILLS |
106 |
0.0009 |
| 825 |
BLOOD PRESSURE DECREASED |
60 |
0.0009 |
| 826 |
ACCIDENTAL OVERDOSE |
33 |
0.0009 |
| 827 |
CONVULSION |
51 |
0.0009 |
| 828 |
HAEMORRHAGE |
93 |
0.0009 |
| 829 |
CHROMATURIA |
20 |
0.0009 |
| 830 |
VOMITING |
416 |
0.0009 |
| 831 |
GLAUCOMA |
17 |
0.0009 |
| 832 |
SKIN CANCER |
19 |
0.0009 |
| 833 |
OSTEOPOROSIS |
36 |
0.0009 |
| 834 |
VERTIGO |
53 |
0.0009 |
| 835 |
DRUG INTOLERANCE |
84 |
0.0009 |
| 836 |
NEURALGIA |
21 |
0.0009 |
| 837 |
NEUROPATHY PERIPHERAL |
82 |
0.0009 |
| 838 |
RECTAL HAEMORRHAGE |
37 |
0.0009 |
| 839 |
ORAL PAIN |
19 |
0.0008 |
| 840 |
FLUID RETENTION |
43 |
0.0008 |
| 841 |
ARRHYTHMIA |
40 |
0.0008 |
| 842 |
DEAFNESS |
22 |
0.0008 |
| 843 |
SKIN DISORDER |
28 |
0.0008 |
| 844 |
VISUAL IMPAIRMENT |
104 |
0.0008 |
| 845 |
TASTE DISORDER |
17 |
0.0008 |
| 846 |
EXPOSURE DURING PREGNANCY |
52 |
0.0008 |
| 847 |
GOUT |
15 |
0.0008 |
| 848 |
LETHARGY |
48 |
0.0008 |
| 849 |
RESTLESSNESS |
30 |
0.0008 |
| 850 |
RASH PAPULAR |
18 |
0.0008 |
| 851 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
57 |
0.0008 |
| 852 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
23 |
0.0008 |
| 853 |
INFLUENZA |
89 |
0.0008 |
| 854 |
CHOLELITHIASIS |
26 |
0.0008 |
| 855 |
BLOOD URINE PRESENT |
15 |
0.0008 |
| 856 |
NO ADVERSE EVENT |
143 |
0.0008 |
| 857 |
ABDOMINAL DISTENSION |
82 |
0.0008 |
| 858 |
FAECES DISCOLOURED |
17 |
0.0008 |
| 859 |
SWELLING FACE |
51 |
0.0008 |
| 860 |
GASTROOESOPHAGEAL REFLUX DISEASE |
63 |
0.0008 |
| 861 |
PRODUCT PRESCRIBING ISSUE |
17 |
0.0008 |
| 862 |
MATERNAL EXPOSURE DURING PREGNANCY |
69 |
0.0008 |
| 863 |
RHINORRHOEA |
50 |
0.0008 |
| 864 |
EYE SWELLING |
28 |
0.0008 |
| 865 |
COGNITIVE DISORDER |
35 |
0.0007 |
| 866 |
AGITATION |
55 |
0.0007 |
| 867 |
ASTHENIA |
273 |
0.0007 |
| 868 |
ANHEDONIA |
19 |
0.0007 |
| 869 |
NEOPLASM PROGRESSION |
25 |
0.0007 |
| 870 |
MENTAL DISORDER |
31 |
0.0007 |
| 871 |
EPISTAXIS |
53 |
0.0007 |
| 872 |
VISION BLURRED |
97 |
0.0007 |
| 873 |
BRONCHITIS |
52 |
0.0007 |
| 874 |
BLOOD POTASSIUM DECREASED |
21 |
0.0007 |
| 875 |
PLASMA CELL MYELOMA |
27 |
0.0007 |
| 876 |
TYPE 2 DIABETES MELLITUS |
23 |
0.0007 |
| 877 |
PSYCHOTIC DISORDER |
20 |
0.0007 |
| 878 |
MYALGIA |
115 |
0.0007 |
| 879 |
PRODUCT PRESCRIBING ERROR |
16 |
0.0007 |
| 880 |
DYSPNOEA |
377 |
0.0007 |
| 881 |
HALLUCINATION |
50 |
0.0007 |
| 882 |
OVERDOSE |
141 |
0.0007 |
| 883 |
NIGHT SWEATS |
21 |
0.0007 |
| 884 |
RASH PRURITIC |
35 |
0.0006 |
| 885 |
SWELLING |
60 |
0.0006 |
| 886 |
HYPOGLYCAEMIA |
31 |
0.0006 |
| 887 |
SINUSITIS |
64 |
0.0006 |
| 888 |
INFUSION RELATED REACTION |
41 |
0.0006 |
| 889 |
DYSKINESIA |
25 |
0.0006 |
| 890 |
LABORATORY TEST ABNORMAL |
18 |
0.0006 |
| 891 |
EXTRAPYRAMIDAL DISORDER |
15 |
0.0006 |
| 892 |
THERAPY CESSATION |
31 |
0.0006 |
| 893 |
NAUSEA |
477 |
0.0006 |
| 894 |
RASH |
258 |
0.0006 |
| 895 |
UNDERDOSE |
43 |
0.0006 |
| 896 |
CHEST DISCOMFORT |
60 |
0.0006 |
| 897 |
INTESTINAL OBSTRUCTION |
22 |
0.0006 |
| 898 |
OROPHARYNGEAL PAIN |
54 |
0.0006 |
| 899 |
BLOOD CHOLESTEROL INCREASED |
27 |
0.0006 |
| 900 |
MALIGNANT NEOPLASM PROGRESSION |
59 |
0.0006 |
| 901 |
RASH MACULAR |
20 |
0.0006 |
| 902 |
ERYTHEMA |
117 |
0.0006 |
| 903 |
ANGINA PECTORIS |
16 |
0.0006 |
| 904 |
AMNESIA |
35 |
0.0005 |
| 905 |
DYSARTHRIA |
20 |
0.0005 |
| 906 |
DEATH |
456 |
0.0005 |
| 907 |
THERAPEUTIC RESPONSE DECREASED |
32 |
0.0005 |
| 908 |
CONSTIPATION |
115 |
0.0005 |
| 909 |
TINNITUS |
24 |
0.0005 |
| 910 |
CATARACT |
31 |
0.0005 |
| 911 |
HYPOACUSIS |
22 |
0.0005 |
| 912 |
BONE DENSITY DECREASED |
16 |
0.0005 |
| 913 |
CHEST PAIN |
93 |
0.0005 |
| 914 |
MUSCULAR WEAKNESS |
57 |
0.0005 |
| 915 |
SKIN EXFOLIATION |
42 |
0.0005 |
| 916 |
LOSS OF CONSCIOUSNESS |
63 |
0.0005 |
| 917 |
HEART RATE INCREASED |
48 |
0.0005 |
| 918 |
GASTRIC DISORDER |
16 |
0.0005 |
| 919 |
MUSCULOSKELETAL PAIN |
24 |
0.0005 |
| 920 |
ABDOMINAL DISCOMFORT |
76 |
0.0005 |
| 921 |
HEADACHE |
284 |
0.0005 |
| 922 |
BLISTER |
25 |
0.0004 |
| 923 |
CEREBROVASCULAR ACCIDENT |
75 |
0.0004 |
| 924 |
DISCOMFORT |
27 |
0.0004 |
| 925 |
MALAISE |
192 |
0.0004 |
| 926 |
INFLUENZA LIKE ILLNESS |
36 |
0.0004 |
| 927 |
NEPHROLITHIASIS |
20 |
0.0004 |
| 928 |
ANGIOEDEMA |
19 |
0.0004 |
| 929 |
ILLNESS |
43 |
0.0004 |
| 930 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
20 |
0.0004 |
| 931 |
ANAPHYLACTIC REACTION |
23 |
0.0004 |
| 932 |
DYSPHONIA |
24 |
0.0004 |
| 933 |
MUSCULOSKELETAL STIFFNESS |
34 |
0.0004 |
| 934 |
HOSPITALISATION |
59 |
0.0004 |
| 935 |
DRY EYE |
19 |
0.0004 |
| 936 |
SLEEP DISORDER |
26 |
0.0004 |
| 937 |
DYSGEUSIA |
27 |
0.0004 |
| 938 |
NASOPHARYNGITIS |
66 |
0.0004 |
| 939 |
WEIGHT INCREASED |
80 |
0.0004 |
| 940 |
FATIGUE |
276 |
0.0004 |
| 941 |
HYPOAESTHESIA |
53 |
0.0004 |
| 942 |
BLOOD PRESSURE INCREASED |
54 |
0.0004 |
| 943 |
PERIPHERAL SWELLING |
53 |
0.0003 |
| 944 |
INCORRECT DOSE ADMINISTERED |
78 |
0.0003 |
| 945 |
INSOMNIA |
91 |
0.0003 |
| 946 |
BONE PAIN |
20 |
0.0003 |
| 947 |
JOINT SWELLING |
40 |
0.0003 |
| 948 |
ABDOMINAL PAIN UPPER |
68 |
0.0003 |
| 949 |
SOMNOLENCE |
66 |
0.0003 |
| 950 |
MEDICATION ERROR |
18 |
0.0003 |
| 951 |
CARDIAC FAILURE CONGESTIVE |
26 |
0.0003 |
| 952 |
NASAL CONGESTION |
19 |
0.0003 |
| 953 |
DIZZINESS |
160 |
0.0003 |
| 954 |
INTENTIONAL PRODUCT MISUSE |
28 |
0.0003 |
| 955 |
SYNCOPE |
32 |
0.0003 |
| 956 |
BLOOD GLUCOSE INCREASED |
60 |
0.0003 |
| 957 |
DYSPEPSIA |
31 |
0.0003 |
| 958 |
EMOTIONAL DISTRESS |
38 |
0.0003 |
| 959 |
BACK PAIN |
72 |
0.0003 |
| 960 |
PRURITUS |
118 |
0.0003 |
| 961 |
DEPRESSION |
68 |
0.0003 |
| 962 |
PAIN |
178 |
0.0003 |
| 963 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
52 |
0.0003 |
| 964 |
FALL |
91 |
0.0003 |
| 965 |
PALPITATIONS |
32 |
0.0003 |
| 966 |
PAIN IN EXTREMITY |
80 |
0.0003 |
| 967 |
NEOPLASM MALIGNANT |
18 |
0.0003 |
| 968 |
ANXIETY |
76 |
0.0003 |
| 969 |
PARAESTHESIA |
42 |
0.0003 |
| 970 |
BALANCE DISORDER |
23 |
0.0003 |
| 971 |
ILL-DEFINED DISORDER |
16 |
0.0003 |
| 972 |
HYPERSENSITIVITY |
48 |
0.0003 |
| 973 |
THERAPY INTERRUPTED |
18 |
0.0003 |
| 974 |
GAIT DISTURBANCE |
48 |
0.0003 |
| 975 |
UNEVALUABLE EVENT |
18 |
0.0002 |
| 976 |
ALOPECIA |
46 |
0.0002 |
| 977 |
ADVERSE EVENT |
21 |
0.0002 |
| 978 |
INJURY |
16 |
0.0002 |
| 979 |
MEMORY IMPAIRMENT |
31 |
0.0002 |
| 980 |
CONTUSION |
21 |
0.0002 |
| 981 |
HYPERHIDROSIS |
28 |
0.0002 |
| 982 |
CARDIAC DISORDER |
20 |
0.0002 |
| 983 |
ARTHRALGIA |
85 |
0.0002 |
| 984 |
DRY SKIN |
27 |
0.0002 |
| 985 |
URTICARIA |
32 |
0.0002 |
| 986 |
PRODUCT DOSE OMISSION ISSUE |
55 |
0.0002 |
| 987 |
SUICIDAL IDEATION |
17 |
0.0002 |
| 988 |
MYOCARDIAL INFARCTION |
31 |
0.0002 |
| 989 |
MUSCLE SPASMS |
27 |
0.0001 |
| 990 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
24 |
0.0001 |
| 991 |
DRUG DOSE OMISSION |
19 |
0.0001 |
| 992 |
FEELING ABNORMAL |
15 |
0.0001 |